1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Lymphoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, H | 1 |
| Bussolino, F; Camussi, G; Ferrando, ML; Foa, R; Malavasi, F | 1 |
| Andreesen, R; Costabel, U; Löhr, GW; Luckenbach, GA; Munder, PG; Osterholz, J; Schulz, A; Speth, V | 1 |
| Denizot, Y; Dupuis, F; Praloran, V; Trimoreau, F; Verger, C | 1 |
| Denizot, Y; Dupuis, F; Liozon, E; Praloran, V; Trimoreau, F | 1 |
| Levine, L | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Lymphoma
| Article | Year |
|---|---|
Platelet-activating factor acetylhydrolase.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Brain; Catalytic Domain; Dimerization; Humans; Isoenzymes; Lymphoma; Microtubule-Associated Proteins; Phospholipases A; Platelet Activating Factor; Protein Structure, Tertiary; Protein Subunits; Substrate Specificity | 2002 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Lymphoma
| Article | Year |
|---|---|
Release of platelet-activating factor (PAF)-like material from human lymphoid cell lines.
Topics: B-Lymphocytes; Burkitt Lymphoma; Cell Line; HLA Antigens; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Platelet Activating Factor; T-Lymphocytes | 1984 |
Tumor cytotoxicity of human macrophages after incubation with synthetic analogues of 2-lysophosphatidylcholine.
Topics: Antineoplastic Agents; Cell Line; Cytotoxicity, Immunologic; Humans; In Vitro Techniques; Lymphoma; Lysophosphatidylcholines; Macrophage Activation; Macrophages; Phospholipid Ethers; Platelet Activating Factor | 1984 |
Platelet-activating factor concentrations in bone marrow of patients with lymphoid and nonlymphoid hematologic malignancies.
Topics: Aged; Bone Marrow; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Platelet Activating Factor; Waldenstrom Macroglobulinemia | 1995 |
Decreased levels of platelet-activating factor in blood of patients with lymphoid and nonlymphoid hematologic malignancies.
Topics: Adolescent; Adult; Aged; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Platelet Activating Factor; Waldenstrom Macroglobulinemia | 1995 |
Regulation of arachidonic acid metabolism by phenylarsine oxide.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acids; Arsenicals; Bradykinin; Calcimycin; Cell Line; Epoprostenol; Kinetics; Liver; Lymphoma; Mice; Platelet Activating Factor; Rats | 1991 |